Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Schrodinger, Inc. - Common Stock
(NQ:
SDGR
)
19.22
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Schrodinger, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28
February 13, 2023
From
Schrödinger
Via
Business Wire
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
February 04, 2023
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a...
Via
Talk Markets
Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know
January 31, 2023
Via
Benzinga
Schrödinger to Present at SVB Securities Global Biopharma Conference
January 31, 2023
From
Schrödinger
Via
Business Wire
4 Analysts Have This to Say About Schrodinger
January 31, 2023
Via
Benzinga
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
January 21, 2023
Mabwell Biosciences out-licensed global rights for a rare disease drug to Disc Medicine of Cambridge, MA in a $412.5 million agreement. Mabwell will receive $10 million upfront, $402.5 million in...
Via
Talk Markets
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities
January 09, 2023
From
Schrödinger, Inc.
Via
Business Wire
Why These 7 Healthcare Stocks Could Soar in 2023
January 02, 2023
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.
Via
InvestorPlace
7 Drug Stocks That Will Soar in 2023
December 22, 2022
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years.
Via
InvestorPlace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 16, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting
December 12, 2022
From
Schrödinger
Via
Business Wire
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
During Monday's session, 49 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
December 02, 2022
On Friday, 72 companies hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 28, 2022
Via
Benzinga
Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
Schrödinger
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
On Monday, 79 companies reached new 52-week lows.
Via
Benzinga
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 18, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference
November 07, 2022
From
Schrödinger
Via
Business Wire
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
November 07, 2022
U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
3 Hypergrowth Stocks That Will Make You a Millionaire by 2027
November 04, 2022
These companies' great third-quarter results, along with their very promising technologies, are likely to turn them into hypergrowth stocks.
Via
InvestorPlace
Schrödinger Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Schrödinger, Inc.
Via
Business Wire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
Schrödinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting
November 03, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce Third Quarter 2022 Financial Results on November 3
October 20, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Hosts Platform Day
October 06, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Host Platform Day on October 6, 2022
September 20, 2022
From
Schrödinger, Inc.
Via
Business Wire
Earnings Scheduled For November 3, 2022
November 03, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.